Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• New study provides insights on how SM impacts the respiratory system

  SM is a risk factor for the development of respiratory symptoms, regardless of whether it presents as indolent SM or advanced SM.

• New program expands access to bezuclastinib for SM

  A new expanded access program (EAP) has been launched for patients with SM, allowing eligible patients to receive bezuclastinib.

• Phase 2 trial explores bezuclastinib for advanced systemic mastocytosis

  A Phase 2 clinical study called Apex is currently evaluating the safety and efficacy of bezuclastinib in patients with advanced SM.

• Researchers identify potential new biomarkers of SM

  Mast cells in patients with systemic mastocytosis (SM) appear to express increased levels of galectin-3 and galectin-8.

• Reporting of SM and other mast cell disorders is rising, study finds

  The use of diagnostic codes for mast cell disorders, such as systemic mastocytosis (SM), appears to be on the rise.

• New data reveals high emotional impact of indolent systemic mastocytosis

  Patients with indolent SM experience significant limitations in their daily lives that directly correlate with symptom burden.

• New review examines bone health testing and treatment for patients with SM

  Learn about the current challenges and emergent therapies for bone health in patients with indolent SM.

• Anemia as initial presentation of SM: Case report

  A recent case study highlights how anemia and low platelet counts can be the initial presentation of systemic mastocytosis (SM).

• Case report examines SM as a cause of chronic diarrhea

  A recently published case report highlighted systemic mastocytosis (SM) as a possible cause of chronic diarrhea.

• New insights into SM genetics could improve treatment and diagnosis

  Different KIT mutations in patients with systemic mastocytosis (SM) appear to correlate with certain findings under the microscope.